Press Releases

Trial Runners is pleased to announce additions to their executive team as well as their leadership team as a result of a fast-paced growth year. - August 17, 2018 - Trial Runners

CTi (Clinical Trials Intelligence) aims to bring down the cost of medicine, as well as increase the speed of access to new medicine, by reducing development costs for the global pharmaceutical industry. - August 08, 2018 - ClinTex Ltd

ALPCO will promote the expansion of its STELLUX® Chemiluminescence ELISA platform, as well as its current therapeutic drug monitoring portfolio, gastroenterology testing panel, and assay qualification program at AACC’s 70th Annual Clinical Lab Expo. - July 25, 2018 - ALPCO

ALPCO and InSphero announce partnership to provide customers with a complete solution to assess beta-cell function in islet microtissue culture models. - July 24, 2018 - ALPCO

The ASAlaser therapeutic solutions are an effective answer in order to successfully treat one of the most common issues for freestyle and backstroke lovers. Hilterapia® and MLS® provide a fast reduction in pain and a speedy recovery of the joint’s action. - July 22, 2018 - ASA srl

Cayman has increased its financial support of the LIPID MAPS® Lipidomics Gateway. The newly launched LIPID MAPS® website (June 2018) provides easy access to free tools and resources, including a searchable lipid structure database (with over 43,000 entries), mass spectrometry spectra prediction tools, lipid structure drawing tools, experimental protocols, systems biology pathway maps, statistical analysis tools, and a curated lipid standards database. - July 21, 2018 - Cayman Chemical Company

Sensitive and direct measurement of cGAMP levels in cell lysates is now possible with Cayman’s much-anticipated 2’3’-cGAMP ELISA Kit. Developed by Cayman scientists, in conjunction with expert nucleotide scientists at Biolog Life Science Institute in Germany, this competitive assay... - July 20, 2018 - Cayman Chemical Company

Dr. Chintan Patel to discuss the implementation of AI & machine learning in clinical development. - July 19, 2018 - Applied Informatics

Celebrating its 25th year in business Minus K Technology, Inc. is giving away $20,000* worth of patented vibration isolators to colleges within the United States. - July 18, 2018 - Minus K Technology Inc.

ALPCO, a leading producer of research and clinical immunoassays, recently announced the launch of its STELLUX® Chemi Active GLP-1 (7-36) amide ELISA. The chemiluminescence ELISA features increased sensitivity to accurately quantify active GLP-1 (7-36) amide levels as low as 1.5 pg/mL with a 25 µL... - July 17, 2018 - ALPCO

Platelet expert, Dr. Alan Michelson has begun consulting as a Scientific Advisor to LightIntegra Technology, the creators of the ThromboLUX System. - June 26, 2018 - LightIntegra Technology

The inaugural Speaking of NEC: Unplugged event, a one-day regional conference focused on identifying practical solutions for reducing the devastating effects of Necrotizing Enterocolitis (NEC) on premature infants and their families took place on June 11, 2018 at the Courtyard by Marriott in Cromwell,... - June 20, 2018 - The Morgan Leary Vaughan Fund, Inc.

ALPCO will promote its new STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at the American Diabetes Association’s 78th Scientific Sessions June 22-26, 2018 in Orlando, FL. - June 19, 2018 - ALPCO

In a pioneering study, scientists led by Dr Wan Yue (Senior Research Scientist) and Professor Niranjan Nagarajan (Associate Director and Senior Group Leader) at the Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS), developed the first rapid, large scale... - June 06, 2018 - Genome Institute of Singapore

Perthera, Inc., the leading Therapeutics Intelligence Company™, is attending the 2018 ASCO Annual Meeting at McCormick Place, Chicago, IL, June 1-5, 2018. Perthera science and clinical results will be represented in a Podium Presentation, 2 Poster Presentations and a Symposium Breakfast. Perthera... - May 30, 2018 - Perthera, Inc.

Adult Stem Cell Released Molecules is a new book on therapeutic development and medicine, by California author Dr. Greg Maguire, Ph.D., that could save lives and restore health. Dr. Greg Maguire's book offers a radically new approach to the standard means of developing therapeutics through the use of the molecules that stem cells release, emphasizing that the molecules act in the organisms through their collective actions within and between all levels of the system, often not at the genome. - May 23, 2018 - BioRegenerative Sciences, Inc.

Perthera, Inc., the leading Therapeutics Intelligence Company™, will be hosting a networking breakfast and educational session on Monday, June 4th from 6:30 – 7:30 a.m. for attendees of the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. The breakfast symposium will be held... - May 22, 2018 - Perthera, Inc.

The immunoassay company Mercodia today announces the launch of MAQS – the Mercodia Assay Quality System. With this program, Mercodia is the first company in the field of immunoassays to set a standard for quality, ensuring customer satisfaction in all parts of its offers. Today, many immunoassay... - May 17, 2018 - Mercodia AB

University of Waterloo’s Kimia receives $3.7M for its AI project for digital pathology. - May 16, 2018 - Kimia Lab, University of Waterloo

Wellness Family Medicine Registered Nurse, Betty Abernathy, has been approved with Aetna. "Aetna health insurance products include medical, pharmacy, dental, behavioral health, group life and disability plans." (https://www.aetna.com/about-us/aetna-facts-and-subsidiaries.html) Betty has been... - May 10, 2018 - Wellness Family Medicine

Patients who are insured by First Choice by Select Health of South Carolina can now be seen by registered nurse Betty Abernathy. - May 09, 2018 - Wellness Family Medicine

Apostle Inc is pleased to announce it’s been accepted into the prestigious StartX accelerator program. StartX is a renowned educational non-profit that accelerates the development of Stanford's top entrepreneurs through experiential education and collective intelligence. The acceptance rate has been between 8%-10%. - May 05, 2018 - Apostle Inc

EpicentRx, a San Diego biotechnology company developing a next-generation immunotherapy platform of viruses that infect and kill cancer cells for the treatment of several tumor types, has developed the first ever series of oncolytic viruses tailored to tumors of individual patients. The first patient,... - May 03, 2018 - EpicentRx, INC

Oxipit’s ChestGlass has been selected as one of the top projects for the 2018 Society for Imaging Informatics in Medicine (SIIM) Innovation Challenge. ChestGlass is the first-to-market chest X-ray search solution that allows to find radiologically similar images in a given database. - April 27, 2018 - Oxipit

In a pioneering study, scientists at A*STAR’s Genome Institute of Singapore (GIS) have developed new machine learning computer models, a type of artificial intelligence (AI), to accurately pinpoint cancer mutations. They have also discovered new mutations in non-coding DNA (specifically, DNA that... - April 23, 2018 - Genome Institute of Singapore

Cayman Chemical has launched a new line of ready-to-use, quantitative lipid standards prepared specifically for mass spectrometry applications. This new line of MaxSpec™ analytical standards complements Cayman’s high-purity, basic research tools that researchers have been using for more than... - April 18, 2018 - Cayman Chemical Company

Previously, it was assumed that ART/IVF success in women using their fresh embryos remains stable until mid-30s before it begins to decline. But a new study of CDC data with almost half a million cycles disproves this and shows success is lower also in very young women, up to age 28, and declining thereafter. Age-driven decline begins earlier than at previously thought mid-30s and occurs at increasing rates. Infertile women older than 30 should not delay ART/IVF treatment, if it is their option. - April 13, 2018 - Stats of the ART

The accommodating features of the MAGNETOM Skyra, combined with 3 Tesla (T) magnet strength – the strongest clinically available– means that Cyrus Diagnostic Imaging patients can now enjoy a larger array of imaging options with high quality images. - April 11, 2018 - Cyrus Diagnostic Imaging

Apostle Inc is pleased to announce the launch of a joint venture with Southern University of Science and Technology (SUSTech) in Shenzhen, China. The joint venture, Apostle-SUSTech Inc, will focus on the scientific and business activities in the Greater China region. David Ge, President of Apostle Inc;... - April 04, 2018 - Apostle Inc

Wellness Family Medicine in Spartanburg, South Carolina is happy to announce that as of March 25, 2018 Registered Nurse, Betty Abernathy, is now in network with TRICARE insurance. - March 31, 2018 - Wellness Family Medicine

MLS® and Hilterapia® prove to be successful in enabling runners and bikers to resume sports activities after forced stops due to painful issues of the ankle-foot-heel. - March 24, 2018 - ASA srl

The Choosing Wisely® in North Carolina initiative – which aims to reduce health care waste by helping patients make smart and effective health care choices – has resulted in significant reductions in the unnecessary use of antibiotics, Pap tests and scans for osteoporosis. - March 23, 2018 - NCHQA

ClinSearch, Clinical Research Specialists announces a transition in leadership at the 25-year-old clinical research site. Dr. Mark M. McKenzie is succeeding ClinSearch founder Dr. Richard A. Krause as medical director. “I have a passion for medical care and the difference it makes in the lives... - March 10, 2018 - Wake Research Associates

Georgia Bio honors ACMR with a Georgia Bio Community Award. - March 03, 2018 - Atlanta Center for Medical Research

Laboratory Development and Supply Company, Clear Scientific expands their scientific cannabis product line. - March 01, 2018 - Clear Scientific

Ostium makes it possible to detect illnesses at the stage of early functional disruptions, long before the onset of the first noticeable symptoms. Moreover, Ostium are able to predict, well in advance, many serious ailments, from asthma to tumors. Ostium Lab launch a crowdfunding campaign with IndieGoGo to continue their project, to improve the hardware and software complex, to process state registration and to launch mass production. - February 26, 2018 - Ostium

The Joint Project Management Office for Medical Countermeasure Systems (JPM-MCS) Next Generation Diagnostic System Increment 1 (NGDS Inc 1) program has been named a finalist in the Medical/Dental category for the 2018 Edison Awards. Established in 1987 and often described as “the Oscars of Innovation,”... - February 26, 2018 - JPM-MCS

Experimentica Ltd. has been selected for Phase 1 of the Young Innovative Company program by Business Finland (formerly known as TEKES, The Finnish Funding Agency for Technology and Innovation). The funding awarded for the first phase is a 250,000 € grant for a period of 12 months. “Every... - February 21, 2018 - Experimentica Ltd

Medical Evolutions 1 Inc. was established to educate the general public on becoming “empowered” in participating in their own healthcare along with their physician via the Medical Evolutions 1 Inc. Pharmacogenomic Comprehensive ME TEST™. The goal is to make the ordering and utilization of the test a simple, uncomplicated yet an effective process as well as making the test economically available to most. - February 21, 2018 - Medical Evolutions 1 Inc.

Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with Blue Faery, the leading Hepatocellular Carcinoma advocacy group in the US, with the goal to provide liver cancer patients with therapeutic treatment options precisely matched to their individual cancers. “At... - February 20, 2018 - Perthera, Inc.

Apostle Inc is pleased to announce the appointment of Alexander J. Hartemink, PhD as a new member to its Scientific Advisory Board. Dr. Hartemink is Professor of Computer Science and Biology at Duke University. He is the faculty director of the Office of Undergraduate Scholars and Fellows and the active... - February 19, 2018 - Apostle Inc

Turnover has increased by 13% compared with 2016, staff has increased by 20%, 14% of investment in research and the launch of a new therapeutic solution: these are the figures of the year which has just ended for the company that has made laser therapy its flagship of excellence. The 2018 objective? Growth marked by internationalisation. - February 17, 2018 - ASA srl

Wellness Family Medicine in Spartanburg, South Carolina has been approved to accept TRICARE insurance. - February 13, 2018 - Wellness Family Medicine

Apostle Inc is pleased to announce the appointment of David B. Goldstein, PhD as a new member to its Scientific Advisory Board. Dr. Goldstein is John E. Borne Professor of Medical and Surgical Research at Columbia University. - February 11, 2018 - Apostle Inc

With highly qualified sales and support staff covering both Canada and the United States and extensive expertise in supplying the life sciences with novel and high quality scientific instrumentation, Scintica is perfectly placed to partner with Oxford Optronix. The Scintica team consists of scientists,... - February 07, 2018 - Scintica Instrumentation

Latest innovation in cryostorage planning expand options for reproductive tissue disposition. - February 01, 2018 - ReproTech, Ltd.

Mopec, an industry leading manufacturer and distributor of high quality pathology, anatomy, mortuary, and necropsy equipment and products, is pleased to announce the addition of Sally Brandtneris and Dr. Joyce deJong to the Company’s Board of Directors. - January 31, 2018 - Mopec

NanoHybrids, announces the launch of PAtrace, a proprietary nanoparticle that provides high resolution visualization and verification of the enhanced permeability and retention (EPR) effect in heterogeneous tumor models. PAtrace is being launched at the 2018 SPIE BioS Expo. - January 29, 2018 - NanoHybrids

Eagle Biosciences, Inc. is proud to announce the launch of a new assay, MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit. MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit utilizes a simple 96 well sandwich ELISA procedure that measures ONLY the full-length active form (intact form) in under three hours. - January 26, 2018 - Eagle Biosciences, Inc.

Wake Research Welcomes Christine Heironimus as New Director of Business Development and Strategic Network Acceleration. - January 25, 2018 - Wake Research Associates